Company / Operating Cash Flow
KESTRA MEDICAL TECHNOLOGIES, LTD. Operating Cash Flow History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$77.6M
FY2024
5-year range
-$77.6M / -$72.2M
FY2023-FY2024
Trend
-7.4%
vs FY2023
Sector context
#156 of 164
Health Care
What the data says
Among 164 Health Care companies, KESTRA MEDICAL TECHNOLOGIES, LTD. is in the bottom 5% for operating cash flow.
Based on SEC 10-K filings.
-$78M in FY2024.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 164This company -$77.6M Sector average $1.0B
▼
-107.4% below sector average
Key checks
Key Insights
- In FY2024, operating cash flow decreased 7.4% year-over-year.
- Ranks #156 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$77.6M | -7.4% |
| FY2023 | -$72.2M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026